drugset / Trial / NCT02197806

Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia

NCT02197806

Phase 2 Completed 65 enrolled Allergan
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A study to evaluate the safety and efficacy of AGN-199201 alone, AGN-190584 alone and concurrent use of AGN-199201 and AGN-190584 in patients with presbyopia (inability to focus for near vision).

Timeline

Start
2014-07
Primary completion
2014-10
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject AGN-190584 Unknown Other
Subject Oxymetazoline Other / unclassified Other

Indications